Clinical Trial Update: Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy [Phase 3]

View source ↗

Summary

Open-label Phase 3 safety and efficacy study of levetiracetam in Korean patients with partial epilepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy, Partial | Phase 3 | Status: COMPLETED